🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to compare the tolerability of nebivolol to m...
Status
Terminated
Location
Forest Research Institute 014
Start Date
2007-10-31
Trial ID
NCT00547300
Treatments Being Tested
As the cancer-related prognosis improves thanks to recent advances in cance...
Status
Unknown
Location
IRCCS Humanitas Research Hospital
Start Date
2019-01-01
Trial ID
NCT05728632
The purpose of this study is to directly compare the blood pressure (hypert...
Status
Withdrawn
Location
University of Mississippi Medical Center
Start Date
2010-02
Trial ID
NCT01076140
Treatments Being Tested
Breast cancer can be managed using chemotherapy, endocrine therapy and biol...
Status
Recruiting
Location
National Cancer Institute- Cairo University- Egypt
Start Date
2025-01-01
Trial ID
NCT07233499
Treatments Being Tested
This was a prospective, open-label, randomized, parallel pilot clinical stu...
Status
Completed
Location
Kafrelsheikh University
Start Date
2024-03-01
Trial ID
NCT07397481
Treatments Being Tested
This study is designed to answer the question as to whether the sympathetic...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2015-07-01
Trial ID
NCT02467400
Treatments Being Tested
Summary: * Study title: Effects of Nebivolol on subclinical left ventricul...
Status
Completed
Location
University and Emergency Hospital
Start Date
2005-04
Trial ID
NCT00942487
Within large number of patients with obesity, it is crucial to determine wh...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2011-04-01
Trial ID
NCT01358409
Treatments Being Tested
The study is to compare the rate and extent of absorption of a generic form...
Status
Unknown
Location
Multiple Locations
Start Date
2025-02-04
Trial ID
NCT06289881
Treatments Being Tested
This is a 26-week, prospective double-blind, randomized pilot trial of nebi...
Status
Completed
Location
Thomas Jefferson University
Start Date
2011-08
Trial ID
NCT01499134
Treatments Being Tested